#pseudomonas — Wednesday, September 16, 2026 (1 items)
| 0 | ℹ |
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-09-16 | #amr #antibiotic #bacteremia #pseudomonas |